Gastroesophageal Reflux Disease

In an exclusive video with Healio Gastroenterology, Loren Laine, MD, FACG, chair of the Digestive Disease Week counsel, Yale School of Medicine, highlighted a few presentations from Digestive Disease Week.

Progress in the non-endoscopic detection for Barrett’s esophagus may lead to increased identification of those at risk for esophageal adenocarcinoma, according to opinions published in Annals of Internal Medicine.

Endoscopic full-thickness fundoplication was safe and effective for the improvement of quality of life in patients with proton pump inhibitor-dependent gastroesophageal reflux disease, according to a study published in Gut.

Short meal-to-bedtime may be a predominant risk factor of gastroesophageal reflux disease in pregnant women, according to a study published in the Journal of Clinical Gastroenterology.

In a new study, the odds of having gastroesophageal reflux disease were nearly two times higher in patients with idiopathic pulmonary fibrosis compared with adults without idiopathic pulmonary fibrosis.

Cancer survivors developing a second, different cancer is a concern among physicians. Various factors, including prior treatment, can potentially increase a patient’s risk for developing another malignancy, experts said.

GERD appeared to increase risk for esophageal adenocarcinoma, esophageal squamous cell carcinoma and laryngeal squamous cell carcinoma, according to results of a study published in Cancer.

A recent study showed that gut microbiome composition may impact the severity of COVID-19. It was the top story in gastroenterology last week.

Pneumatic dilation, or PD, with a 35-mm balloon compared with sham dilation was not superior for the treatment of persistent dysphagia after fundoplication, according to a study published in Gut.

Women who adhered to an anti-reflux lifestyle had a decreased risk for gastroesophageal reflux disease symptoms, possibly preventing up to 40% of symptoms that occur weekly, according to study results.